14 research outputs found

    Highly Sensitive SERS Detection of Hg<sup>2+</sup> Ions in Aqueous Media Using Gold Nanoparticles/Graphene Heterojunctions

    No full text
    Gold nanoparticles (AuNPs)/reduced graphene oxide (rGO) heterojunctions were synthesized directly on SiO<sub>2</sub>/Si substrates via a seed-assisted growth process. The in situ chemical fabrication strategy has been proven to be quite simple and efficient for generating highly active surface-enhanced Raman scattering (SERS) substrates due to synergistic enhanced protocol from rGO and AuNPs. The SERS substrates with AuNPs/rGO heterojunctions have been utilized for trace analysis of mercury­(II) ions via thymine–Hg<sup>2+</sup>–thymine coordination. Thereby, very low limits of detection, i.e., 0.1 nM or 20 ppt for Hg<sup>2+</sup>, can be achieved in contrast with some other SERS subsrtates, which suggests that the heterojunctions are appropriate as versatile surface-enhanced substrates applied in chemical sensing or biosensing

    Results of correlation analysis between clinical variables and GMV in MDD group.

    No full text
    <p>GMV: gray matter volume.</p><p>HDRS: Hamilton Depression Rating Scale.</p><p>nMDD: medication-naïve major depressive disorder.</p><p>tMDD: treated major depressive disorder.</p

    Demographic and clinical data of subjects.

    No full text
    <p>S.D.: standard deviation.</p><p>MDD: major depressive disorder.</p><p>HDRS: Hamilton Depression Rating Scale.</p

    Regions of differences in gray matter volume in treated participants with major depressive disorder.

    No full text
    <p>A: the axial image (z = 26 mm Montreal Neurological Institute coordinate plane) shows the regions of significantly increased gray matter volume in left thalamus in treated participants with major depressive disorder, compared to healthy controls (p<0.05, corrected). B: the axial image (z = −6 mm Montreal Neurological Institute coordinate plane) shows the regions of significantly increased gray matter volume in right orbitofrontal cortex in treated participants with major depressive disorder, compared to healthy controls (p<0.05, corrected). The color bar represents the range of <i>T</i> values. R =  right.</p

    Regions of differences in gray matter volume in medication-naïve participants with major depressive disorder.

    No full text
    <p>A: the axial image (z = 8 mm Montreal Neurological Institute coordinate plane) shows the regions of significantly decreased gray matter volume in right dorsolateral prefrontal cortex in medication-naïve participants with major depressive disorder, compared to healthy controls (p<0.05, corrected). B: the axial image (z = 42 mm Montreal Neurological Institute coordinate plane) shows the regions of significantly decreased gray matter volume in left middle frontal gyrus in medication-naïve participants with major depressive disorder, compared to healthy controls (p<0.05, corrected). C: the axial image (z = 11 mm Montreal Neurological Institute coordinate plane) shows the regions of significantly increased gray matter volume in left thalamus in medication-naïve participants with major depressive disorder, compared to healthy controls (p<0.05, corrected). D: the axial image (z = 3 mm Montreal Neurological Institute coordinate plane) shows the regions of significantly increased gray matter volume in right insula in medication-naïve participants with major depressive disorder, compared to healthy controls (p<0.05, corrected). The color bar represents the range of <i>T</i> values. R =  right.</p
    corecore